Old Web
English
Sign In
Acemap
>
Paper
>
Migalastat 150 mg every other day achieves bioequivalent exposures in adolescent and adult patients with Fabry disease
Migalastat 150 mg every other day achieves bioequivalent exposures in adolescent and adult patients with Fabry disease
2021
Uma Ramaswami
Cathrine Leonowens
Ozlem Goker-Alpan
William R. Wilcox
Robert J. Hopkin
Amarilis Sanchez-Valle
Virginia D. Schmith
Nina Skuban
Franklin K. Johnson
Keywords:
every other day
Pediatrics
adult patients
Medicine
Fabry disease
Bioequivalence
Migalastat
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]